Install
Biotech
Biotechnology, gene editing, biopharma platforms, and clinical pipelines.
- 9 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
- Aerospace
- Agriculture
- Banking (Industry)
- Computing
- Consumer Goods
- Defense
- Energy & Utilities
- Entertainment
- Food & Beverage
- Government
- Healthcare
- Real Estate (Commercial)
- Management & Consulting
- Manufacturing
- Technology
- Telecom
- Transportation & Logistics
- Automotive
- Construction
- Education & EdTech
- Hospitality & Travel
- Insurance (Industry)
- Mining & Materials
- Pharmaceuticals
Latest in Biotech
Tempest Therapeutics Announces Exclusive Option Agreement with Senlang for CD7-Targeted Lentiviral In Vivo CAR-T Platform and BCMA/GPRC5D Candidate | TPST Stock News
44+ min ago (293+ words) Tempest has signed an exclusive option agreement with Senlang for a CD7-targeted lentiviral vector platform and in vivo CAR-T candidates. It is currently in Phase 1 dose escalation trials for relapsed/refractory multiple myeloma, showing early positive results. The platform allows…...
Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
5+ hour, 33+ min ago (435+ words) Immunocore IMCR announced that it has achieved target enrollment of 540 patients in the phase III TEBE-AM study, which is evaluating its sole marketed drug, Kimmtrak (tebentafusp), in patients with second-line or later advanced melanoma. Overall survival is the primary endpoint…...
BreezeBio Appoints Biopharma Executive Kevin Sin to Board of Directors
7+ hour, 18+ min ago (557+ words) BreezeBio has appointed biopharmaceutical executive Kevin Sin to its board of directors as an independent director, adding more than 30 years of business development, corporate strategy and operational experience as the company advances genetic medicines built on its NanoGalaxy delivery platform....
Beta Bionics Announces Proposed Public Offering of $125.0 Million of Common Stock
41+ min ago (377+ words) marketscreener.com 15, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc (Nasdaq: BBNX) today announced that it intends to offer and sell, in an underwritten public offering and subject to market and other conditions, $125.0 million of shares of its common stock All of the…...
RCUS: Pivotal ARC-20 data and phase III trials aim to establish casdatifan as a market leader in RCC
2+ hour, 53+ min ago (84+ words) TradingView Casdatifan is positioned as a transformative therapy in renal cell carcinoma, with pivotal data from ARC-20 and upcoming phase III trials aiming to demonstrate superiority across all lines of therapy. Commercial plans target multi-billion dollar opportunities, with key data…...
RPG Life Sciences completes slump sale of APIs business to Raghava
25+ min ago (327+ words) The transaction was executed through a Business Transfer Agreement (BTA) between Raghava Life Sciences and RPG Active Pharma Limited, a wholly owned subsidiary of RPG Life Sciences. The deal involves the acquisition of the APIs and intermediates businesses as a…...
BBOT: Strategic focus on innovative RAS-targeted therapies, with AI-driven efficiency and strong clinical progress
1+ hour, 20+ min ago (71+ words) TradingView China's rapid drug development is reshaping biotech competition, but innovation remains a key differentiator. AI integration is accelerating research and reducing costs, while clinical programs are strategically focused on high-priority indications with promising efficacy and safety data. Based on…...
OCGN: Late-stage gene therapies advance toward 2027–2028 BLA filings, backed by strong data and funding
55+ min ago (80+ words) TradingView OCGN: Late-stage gene therapies advance toward 2027–2028 BLA filings, backed by strong data and funding Three late-stage gene therapy programs are advancing toward BLA submissions, with top-line data for retinitis pigmentosa and Stargardt disease expected in 2027 and geographic atrophy in…...
Puig to Take Full Ownership of Isdin in $1.39 Billion Deal
5+ hour, 12+ min ago (249+ words) The deal is a strategic move for Puig to diversify its portfolio. WHO: Founded in 1975 through a partnership between the Puig and Esteve families, Isdin has built an international presence in dermatology and skincare. The Spanish skincare label is stocked…...
Buried knowledge could cost pharma billions. Here???s how to fix it
4+ hour, 37+ min ago (876+ words) A global pharmaceutical company already has the competitive report it needs. The problem is that the report is buried somewhere within the organisation’s information stores, and the marketing specialist who needs it cannot find it. They spend the next two…...